Literature DB >> 24650757

Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells.

Su Bo1, He Hui2, Wang Li2, Ling Hui2, Xia Hong2, Dong Lin2, Wen-Xiang Dai3, You-Hua Wu3, Xiao-Hong Ai3, Jiang Hao4, Su Qi5.   

Abstract

Diallyl disulfide (DADS) has been shown to cause G2/M phase cell cycle arrest in several human cancers. Here we demonstrate a mechanism by which DADS induces G2/M phase arrest in BGC823 human gastric cancer cells via Chk1. From cell cycle gene array results, we next confirmed that cyclin B1 expression was decreased by DADS, while the expression of p21, GADD45α and p53 were increased. Despite the lack of change in Chk1 gene expression in response to DADS according to the array analysis, intriguingly overexpression of Chk1, but not Chk2, exhibited increased accumulation in G2/M phase. Moreover, overexpression of Chk1 promoted the effect of DADS-induced G2/M arrest. Augmented phosphorylation of Chk1 by DADS was observed in Chk1-transfected cells, followed by downregulation of Cdc25C and cyclin B1 proteins. In contrast, phosphorylated Chk2 showed no obvious change in Chk2-transfected cells after DADS treatment. Furthermore, knockdown of Chk1 by siRNA partially abrogated DADS-induced downregulation of Cdc25C and cyclin B1 proteins and G2/M arrest. In contrast, knockdown of Chk2 did not show these effects. Therefore, these data indicate that DADS may specifically modulate Chk1 phosphorylation, and DADS-induced G2/M phase arrest in BGC823 cells could result in part from Chk1-mediated inhibition of the Cdc25C/cyclin B1 pathway.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chk1/2 kinase; Diallyl disulfide; G2/M arrest; Gastric cancer

Mesh:

Substances:

Year:  2014        PMID: 24650757     DOI: 10.1016/j.fct.2014.03.007

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

1.  The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.

Authors:  Chun-Chi Wu; Keh-Feng Huang; Tsung-Ying Yang; Ya-Ling Li; Chi-Luan Wen; Shih-Lan Hsu; Tzu-Hsiu Chen
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

2.  Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.

Authors:  Bo Su; Jian Su; Ying Zeng; Fang Liu; Hong Xia; Yan-Hua Ma; Zhi-Gang Zhou; Shuo Zhang; Bang-Min Yang; You-Hua Wu; Xi Zeng; Xiao-Hong Ai; Hui Ling; Hao Jiang; Qi Su
Journal:  Oncotarget       Date:  2016-03-01

3.  Angiopoietin-like protein 4 potentiates DATS-induced inhibition of proliferation, migration, and invasion of bladder cancer EJ cells; involvement of G2/M-phase cell cycle arrest, signaling pathways, and transcription factors-mediated MMP-9 expression.

Authors:  Seung-Shick Shin; Jun-Hui Song; Byungdoo Hwang; Sung Lyea Park; Won Tae Kim; Sung-Soo Park; Wun-Jae Kim; Sung-Kwon Moon
Journal:  Food Nutr Res       Date:  2017-06-20       Impact factor: 3.894

4.  Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.

Authors:  Jian Su; Yujuan Zhou; Zhibing Pan; Ling Shi; Jing Yang; Aijun Liao; Qianjin Liao; Qi Su
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

Review 5.  Diallyl Disulfide: A Bioactive Garlic Compound with Anticancer Potential.

Authors:  Saikat Mitra; Rajib Das; Talha Bin Emran; Rafiuddin Khan Labib; Fahadul Islam; Rohit Sharma; Islamudin Ahmad; Firzan Nainu; Kumarappan Chidambaram; Fahad A Alhumaydhi; Deepak Chandran; Raffaele Capasso; Polrat Wilairatana
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

6.  MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer.

Authors:  Chuanqing Jing; Rong Fu; Can Wang; Xiurong Li; Wei Zhang
Journal:  Cancer Manag Res       Date:  2021-07-12       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.